{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:23:31Z","timestamp":1787952211354,"version":"build-2784847793"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.rdc.2015.04.008","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T18:47:59Z","timestamp":1432666079000},"page":"475-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Scleroderma Renal Crisis"],"prefix":"10.1016","volume":"41","author":[{"given":"Lo\u00efc","family":"Guillevin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.rdc.2015.04.008_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2007.12.001","article-title":"The many faces of scleroderma","volume":"34","author":"Steen","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"issue":"6698","key":"10.1016\/j.rdc.2015.04.008_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(52)91798-4","article-title":"The kidney of scleroderma","volume":"1","author":"Moore","year":"1952","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.008_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00005792-198311000-00001","article-title":"Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases","volume":"62","author":"Traub","year":"1983","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.008_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","article-title":"The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement","volume":"47","author":"Hunzelmann","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.008_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.008_bib7","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.008_bib8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","article-title":"Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls","volume":"51","author":"Guillevin","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.008_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis","volume":"29","author":"Steen","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.008_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.008_bib11","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.008_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1445-5994.2006.01138.x","article-title":"Scleroderma: it has been a long hard journey","volume":"36","author":"Roberts-Thomson","year":"2006","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.008_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00371817","article-title":"Epidemiological study of patients with systemic sclerosis in Tokyo","volume":"283","author":"Tamaki","year":"1991","journal-title":"Arch Dermatol Res"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.008_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/rheumatology\/keh253","article-title":"Prevalence of systemic sclerosis in a French multi-ethnic county","volume":"43","author":"Le Guern","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"12 Pt 2","key":"10.1016\/j.rdc.2015.04.008_bib15","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0755-4982(06)74923-5","article-title":"Sclerodermie systemique: epidemiologie et facteurs environnementaux","volume":"35","author":"Magnant","year":"2006","journal-title":"Presse Med"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.008_bib16","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.008_bib17","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.008_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.berh.2004.03.001","article-title":"Scleroderma\u2013clinical and pathological advances","volume":"18","author":"Denton","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.008_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.008_bib20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.008_bib21","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/j.1600-6143.2005.01035.x","article-title":"Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature","volume":"5","author":"Pham","year":"2005","journal-title":"Am J Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2015.04.008_bib22","first-page":"iii32","article-title":"Renal complications and scleroderma renal crisis","volume":"48","author":"Denton","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"9523","key":"10.1016\/j.rdc.2015.04.008_bib23","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(06)68737-0","article-title":"Systemic sclerosis: hypothesis-driven treatment strategies","volume":"367","author":"Charles","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.008_bib25","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/art.1780390622","article-title":"Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy","volume":"39","author":"Rivolta","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.008_bib26","first-page":"1163","article-title":"Renal scintigraphy in acute scleroderma: report of three cases","volume":"34","author":"Woolfson","year":"1993","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.008_bib27","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archinte.1977.03630230044013","article-title":"Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?","volume":"137","author":"Gavras","year":"1977","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0002-9343(74)90757-8","article-title":"Juxtaglomerular hyperplasia and hyperreninemia in progressive systemic sclerosis complicated acute renal failure","volume":"56","author":"Stone","year":"1974","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780370110","article-title":"Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followup","volume":"37","author":"Clements","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2015.04.008_bib30","first-page":"iii58","article-title":"Translating ideas into progress in systemic sclerosis","volume":"48","author":"Guillevin","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.008_bib31","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/art.10895","article-title":"Endothelin and endothelin receptor antagonists in systemic rheumatic disease","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.rdc.2015.04.008_bib32","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar2187","article-title":"Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis","volume":"9","author":"Koch","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.008_bib33","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets\u2013a marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.008_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s100670050132","article-title":"Immunohistological study endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis","volume":"18","author":"Kobayashi","year":"1999","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2010.05.018","article-title":"Endothelin-1 expression in scleroderma renal crisis","volume":"42","author":"Mouthon","year":"2011","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.008_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/anr.1780320207","article-title":"Pregnancy in women with systemic sclerosis","volume":"32","author":"Steen","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib37","first-page":"15","article-title":"Pregnancy in women with systemic sclerosis","volume":"94","author":"Steen","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"21","key":"10.1016\/j.rdc.2015.04.008_bib38","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM199205213262116","article-title":"Reversible scleroderma renal crisis after cocaine use","volume":"326","author":"Lam","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/rheumatology\/33.1.90","article-title":"Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases","volume":"33","author":"Denton","year":"1994","journal-title":"Br J Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.008_bib40","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/anr.1780320911","article-title":"Normotensive renal failure in systemic sclerosis","volume":"32","author":"Helfrich","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.008_bib41","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.10589","article-title":"Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial","volume":"46","author":"DeMarco","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"5\u20136","key":"10.1016\/j.rdc.2015.04.008_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1445-5994.2003.00358.x","article-title":"Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment","volume":"33","author":"Walker","year":"2003","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.008_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00124743-200104000-00013","article-title":"Alveolar hemorrhage and pulmonary hypertension in systemic sclerosis: a continuum of scleroderma renal crisis?","volume":"7","author":"Herndon","year":"2001","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.008_bib45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/s10165-004-0379-1","article-title":"Normotensive scleroderma renal crisis with diffuse alveolar damage after corticosteroid therapy","volume":"15","author":"Naniwa","year":"2005","journal-title":"Mod Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.008_bib46","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.008_bib47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.semarthrit.2004.08.008","article-title":"Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis","volume":"34","author":"Manadan","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.008_bib48","first-page":"914","article-title":"Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis)","volume":"88","author":"Mannucci","year":"2003","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.008_bib49","first-page":"557","article-title":"Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis","volume":"22","author":"Molina","year":"1995","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.008_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0272-6386(12)80990-5","article-title":"Scleroderma renal crisis with minimal skin involvement and no serologic evidence of systemic sclerosis","volume":"23","author":"Gonzalez","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.008_bib51","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3899\/jrheum.090815","article-title":"Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients","volume":"37","author":"Avouac","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.008_bib52","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ndt\/12.3.576","article-title":"Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis","volume":"12","author":"Carvajal","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib53","first-page":"86","article-title":"Autoantibodies to myeloperoxidase in systemic sclerosis","volume":"24","author":"Locke","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.008_bib54","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1053\/ajkd.2000.16215","article-title":"Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type","volume":"36","author":"Maes","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.008_bib55","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/0003-4819-126-11-199706010-00003","article-title":"Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease","volume":"126","author":"Merkel","year":"1997","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.008_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5414\/CNP70183","article-title":"Noncrescentic ANCA-associated renal crisis in systemic sclerosis","volume":"70","author":"Mimura","year":"2008","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31827781fd","article-title":"Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature","volume":"92","author":"Qu\u00e9m\u00e9neur","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.008_bib58","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/rheumatology\/ket213","article-title":"Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors","volume":"52","author":"Derrett-Smith","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.008_bib59","first-page":"918","article-title":"Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis","volume":"29","author":"Ruffatti","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.008_bib60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00296-005-0011-5","article-title":"Scleroderma associated with ANCA-associated vasculitis","volume":"26","author":"Rho","year":"2006","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.008_bib61","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2007.05.026","article-title":"D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease","volume":"50","author":"Bienaime","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.008_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.008_bib63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejim.2010.01.004","article-title":"Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma","volume":"21","author":"Faucher","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.008_bib64","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.autrev.2009.02.002","article-title":"Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression","volume":"8","author":"Cavazzana","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.008_bib65","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-119-10-199311150-00007","article-title":"Autoantibody reactive with RNA polymerase III in systemic sclerosis","volume":"119","author":"Okano","year":"1993","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.008_bib66","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/03009742.2011.569753","article-title":"Anti-RNA polymerase III antibodies are associated with scleroderma renal crisis in a French cohort","volume":"40","author":"Emilie","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rdc.2015.04.008_bib67","series-title":"Systemic sclerosis","first-page":"279","article-title":"Renal involvement in systemic sclerosis","author":"Steen","year":"2004"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.008_bib68","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/BOR.0b013e3283108df7","article-title":"Diagnosis, management and prevention of scleroderma renal disease","volume":"20","author":"Penn","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.008_bib69","first-page":"29","article-title":"Pathologic observations concerning the kidney in progressive systemic sclerosis","volume":"65","author":"Fisher","year":"1958","journal-title":"AMA Arch Pathol"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.008_bib70","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.1780310311","article-title":"Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study","volume":"31","author":"Trostle","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.008_bib71","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-113-5-352","article-title":"Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors","volume":"113","author":"Steen","year":"1990","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.008_bib72","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"9052","key":"10.1016\/j.rdc.2015.04.008_bib73","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(05)61568-1","article-title":"Failure of losartan to control blood pressure in scleroderma renal crisis","volume":"349","author":"Caskey","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.008_bib74","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0002-9343(02)01069-0","article-title":"High prevalence of polymorphisms of angiotensin-converting enzyme (I\/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis","volume":"112","author":"Fatini","year":"2002","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.008_bib75","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/qjmed\/hct111","article-title":"Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility","volume":"106","author":"Penn","year":"2013","journal-title":"QJM"},{"issue":"2 Suppl 76","key":"10.1016\/j.rdc.2015.04.008_bib76","first-page":"135","article-title":"Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series","volume":"31","author":"Montanelli","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.008_bib77","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.008_bib78","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/rheumatology\/41.9.965","article-title":"Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition","volume":"41","author":"Maddison","year":"2002","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:55Z","timestamp":1760181235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X15000290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0889857X15000290"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.008","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scleroderma Renal Crisis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}